Literature DB >> 3801765

The contribution of intrinsic activity to the action of opioids in vitro.

L Miller, J S Shaw, E M Whiting.   

Abstract

The effects of opioids were compared in five field-stimulated isolated tissue models, the guinea-pig ileum and vasa deferentia from rat, rabbit and mice of the Alderley Park and C57BL/6 strains. Although the mu-receptor agonist [D-Ala2, MePhe4, Gly-ol5] enkephalin appeared to act at similar receptors in the guinea-pig ileum, rat vas deferens, mouse vas deferens and C57BL/6 mouse vas deferens preparations, its potency varied considerably between these preparations. Similar potency differences were also observed with the kappa-agonist, ethylketocyclazocine. It is proposed that these variations in potency reflect differences in the number of spare receptors present in each model. The finding that some drugs which have agonist activity in the more sensitive preparations behave as antagonists in the less sensitive tissues supports this proposal and highlights the importance of intrinsic activity in determining the action of opioids. Many of the prototypic opioid agonists were found to be either partial agonists (eg. morphine and bremazocine) or to possess affinity for more than one receptor type (eg. ethylketocyclazocine, Mr 2034).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3801765      PMCID: PMC1916558          DOI: 10.1111/j.1476-5381.1986.tb10202.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  Selective receptors for beta-endorphin on the rat vas deferens.

Authors:  R Schulz; E Faase; M Wüster; A Herz
Journal:  Life Sci       Date:  1979-02-26       Impact factor: 5.037

2.  History and development of mixed opioid agonists, partial agonists and antagonists.

Authors:  W R Martin
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

3.  Evidence for a single opioid receptor type on the field stimulated rat vas deferens.

Authors:  C S Liao; A R Day; R J Freer
Journal:  Life Sci       Date:  1981-12-21       Impact factor: 5.037

4.  Rabbit vas deferens: a specific bioassay for opioid kappa-receptor agonists.

Authors:  T Oka; K Negishi; M Suda; T Matsumiya; T Inazu; M Ueki
Journal:  Eur J Pharmacol       Date:  1981-07-17       Impact factor: 4.432

5.  Increase in potencies of opioid peptides after peptidase inhibition.

Authors:  A T McKnight; A D Corbett; H W Kosterlitz
Journal:  Eur J Pharmacol       Date:  1983-01-21       Impact factor: 4.432

6.  Differences in the inhibitory effects of normorphine and opioid peptides on the responses of the vasa deferentia of two strains of mice.

Authors:  A A Waterfield; J A Lord; J Hughes; H W Kosterlitz
Journal:  Eur J Pharmacol       Date:  1978-01-15       Impact factor: 4.432

7.  Endogenous opioid peptides: multiple agonists and receptors.

Authors:  J A Lord; A A Waterfield; J Hughes; H W Kosterlitz
Journal:  Nature       Date:  1977-06-09       Impact factor: 49.962

8.  Hamster vas deferens contains delta-opioid receptors.

Authors:  A T McKnight; A D Corbett; M Marcoli; H W Kosterlitz
Journal:  Neuropeptides       Date:  1984-12       Impact factor: 3.286

9.  The origin of acetylcholine released from guinea-pig intestine and longitudinal muscle strips.

Authors:  W D Paton; M A Zar
Journal:  J Physiol       Date:  1968-01       Impact factor: 5.182

10.  Deltakephalin, Tyr-D-Thr-Gly-Phe-Leu-Thr: a new highly potent and fully specific agonist for opiate delta-receptors.

Authors:  J M Zajac; G Gacel; F Petit; P Dodey; P Rossignol; B P Roques
Journal:  Biochem Biophys Res Commun       Date:  1983-03-16       Impact factor: 3.575

View more
  24 in total

1.  Cross-tolerance and enhanced sensitivity to the response rate-decreasing effects of opioids with varying degrees of efficacy at the mu receptor.

Authors:  M J Picker; J Yarbrough
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Importance of delta opioid receptors in maintaining high alcohol drinking.

Authors:  J C Froehlich; M Zweifel; J Harts; L Lumeng; T K Li
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Inability of an opioid antagonist lacking negative intrinsic activity to induce opioid receptor up-regulation in vivo.

Authors:  B J Morris; M J Millan
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

4.  Reflex peristalsis in the guinea pig isolated ileum is endogenously controlled by kappa opioid receptors.

Authors:  W Kromer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-05       Impact factor: 3.000

5.  Mu and kappa opioid receptor modulation of 5-HT3 and NK-3 receptor-evoked release of acetylcholine from the guinea-pig ileum myenteric plexus.

Authors:  A J Fox; I K Morton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-07       Impact factor: 3.000

6.  Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.

Authors:  C G Parsons; D C West; P M Headley
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

7.  Effects of the delta opioid against BW373U86 in pigeons trained to discriminate fentanyl, bremazocine and water in a three-choice drug discrimination procedure.

Authors:  S S Negus; D Morgan; C D Cook; M J Picker
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

8.  Differential cross-tolerance to mu and kappa opioid agonists in morphine-tolerant rats responding under a schedule of food presentation.

Authors:  M J Picker; S S Negus; K R Powell
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

9.  Guanine nucleotide-binding protein-coupled and -uncoupled states of opioid receptors and their relevance to the determination of subtypes.

Authors:  A Richardson; C Demoliou-Mason; E A Barnard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

10.  Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors.

Authors:  L Negri; R Lattanzi; P Melchiorri
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.